Neil A. Klompas, Chief Operating Officer at Zymeworks Inc. (ZYME), sold 2,979 shares at $6.88 ($20K) on 2022-03-10, disclosed to the SEC on 2022-03-11.
Scheduled sale ($20k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ZYME | SELL | 2020-12-11 | $1.3M | — | Filing → |
| ZYME | SELL | 2019-05-08 | $289K | — | Filing → |